1Emory TG, Gaynes RP. An overview of nosocomial infections including the role of the microbiology laboratory[J]. Clin Microbiol Rev, 1993, 6: 428-442
2Elsner HA, Sobottka I, Feucht HH, et al. In vitro suceptibilities of enterococcal blood culture isolates from the Hanburg area to ten antibiotics[J]. Chemotherapy, 2000, 46(2): 104-110.
3Mollering Rc Jr. Emergence of Enterococcus as a significant pathogen[J]. Clin Infect Dis, 1992, 14(6): 1173.
4Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci[J]. Arch Intern Med, 1996, 156(13): 1458-1462.
5National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement[S]. M100-S9. NCCLS, 1999. 82-83.
6Silverman J, Thal LA, Perri MB, et al. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci[J]. J Clin Microbiol, 1998, 36(3): 830-832.
7Schouten KA, Voss A, Hoogkamp-Korstanje JAA, et al. Antimicrobial susceptibility patterns of enterococci causing infections in Europe[J]. Antimicrob Agents Chemother, 1999, 43(10): 2542-2546.
8Hallgren A, Abednazari H, Ekdahl C, et al. Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems[J]. J Antimicrob Chemother, 2001, 48(1): 53-62.
9Weinstein MP. Comparative evaluation of penicillin, ampicillin and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus feacalis and Enterococcus feacium[J]. J Clin Microbiol, 2001, 39(7): 2729-2731.
10Amin NE, Wretlind E, Wenger A, et al. Ampicillin-sensitive, imipenem-resistant strain of Enterococcus faecium[J]. J Clin Microbiol, 2002, 40(2): 738.
